Status:
COMPLETED
Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Lead Sponsor:
Epigenomics, Inc
Conditions:
Colorectal Cancer
Eligibility:
All Genders
40+ years
Brief Summary
Epigenomics is developing a colon cancer screening assay based on differential methylation of specific CpG sites for the detection of early stage disease. A genome-wide methylation analysis and oligon...
Detailed Description
From public health as well as health economics perspectives, the poor adoption of current screening options limits the effectiveness of CRC screening initiatives; as stated by Sidney Winawer, MD, "the...
Eligibility Criteria
Inclusion
- Group 1 diagnosis of colorectal cancer
Exclusion
- Group 2 diagnosis of colorectal cancer
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT00696345
Start Date
January 1 2005
End Date
February 1 2007
Last Update
June 17 2008
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery and Surgical Oncology, Charité Campus Berlin Buch
Berlin, Germany
2
Department of Visceral-, Thoracic- and Vascular Surgery, University Hospital Carl Gustav Carus
Dresden, Germany, 01307
3
Department of Surgery, University Hospital Schleswig-Holstein, Campus Lübeck
Lübeck, Germany, 23538
4
Völklingen Clinic
Völklingen, Germany